The global lyophilisation for pharmaceuticals products and services market will reach $3.09bn in 2014 with revenues showing strong growth to 2024. With increasing numbers of proteins being discovered, the importance of lyophilisation is coming to the fore, for example, as a means of extending the shelf life of pharmaceutical and biopharmaceutical products.SMi is very pleased to present the 2nd annual Lyophilisation conference on 7-8 July 2014, London. This event will provide an update on methodologies for lyophilisation and examine how to mitigate risks in production. Gain practical information and tools which you can use and apply in the workplace.Key Speakers Include •    Sune Andersen, Principal Scientist, Novo Nordisk •    Patrick Garidel, Associate Director, Protein Science, Boehringer Ingelheim •    Julie Pagenaud, Sterile Product Manufacturing Manager, Ipsen •    Massimo Rastelli, Project Leader BioPharm, GlaxoSmithKline •    Andrea Weiland, CEO, Explicat Pharma •    Mark Yang, Director of Fill Finish Development, Genzyme •    Bertie Daly, Associate Director, Alexion Pharmaceuticals •    Jamie Biddlecombe, Formulation Development Scientist, MedImmune •    Jason Gray, Consultant, Allembis (ex-Merck) •    Professor Dr Thomas de Beer, Laboratory of Process Analytical Technology, Ghent University •    Dr Rongjun Chen, Lecturer in Chemical Engineering, Imperial College LondonKey Topic Insights • First hand case studies from leading experts in lyophilisation • Evaluate practical guidance from both industry and academics • Analyse ways to ensure good product quality at the end of the cycle • Discover the fastest way to delivery within a lyophilisation cycle • How to optimise cycles of products on the marketBOOK BY THE 31ST MARCH AND SAVE £300 BOOK BY 30TH APRIL AND SAVE £100